Neal S. Goldstein, MD, 1 Anjina Soman, MD, 1 and Stuart C. Gordon, MD 2. Abstract
|
|
- Dwain Wilcox
- 5 years ago
- Views:
Transcription
1 Anatomic Pathology / DISTINGUISHING PRIMARY BILIARY CIRRHOSIS FROM AUTOIMMUNE HEPATITIS Portal Tract Eosinophils and Hepatocyte Cytokeratin 7 Immunoreactivity Helps Distinguish Early-Stage, Mildly Active Primary Biliary Cirrhosis and Autoimmune Hepatitis Neal S. Goldstein, MD, 1 Anjina Soman, MD, 1 and Stuart C. Gordon, MD 2 Key Words: Liver; Primary biliary cirrhosis; Autoimmune hepatitis; Cytokeratin 7; Eosinophils; Bile ducts Abstract We studied nondiagnostic liver biopsy specimens from 20 patients with definite primary biliary cirrhosis (PBC) and 18 with definite autoimmune hepatitis (AIH) to identify distinguishing features. All patients had early-stage disease; biopsy specimens were devoid of granulomas or diagnostic features of PBC or AIH. Diagnoses were based on serologic and clinical variables. Sixteen specimens from each group were immunostained with cytokeratin 7. The density of portal tract eosinophils and number with cytokeratin 7 reactive periportal hepatocytes were quantified. Sixteen of 18 patients with AIH and 13 of 20 with PBC had no or minimal bile duct injury. Histologic activity index scores were 5.8 in AIH and 5.7 in PBC. The mean portal eosinophil score was greater in PBC than in AIH. Cytokeratin 7 identified many central bile ducts that were obscured by portal inflammation. The mean periportal cytokeratin 7 reactive hepatocyte score was greater in PBC than in AIH. Portal eosinophils and cytokeratin 7 reactivity in periportal hepatocytes are supportive of PBC rather than AIH. No morphologic features were supportive of AIH. Cytokeratin 7 reactivity in periportal hepatocytes may be an early response to PBC-induced biliary obstruction in other regions of the liver. Primary biliary cirrhosis (PBC) and autoimmune hepatitis (AIH) can be difficult to distinguish. 1-3 Patients with mildly active, early-stage PBC or AIH can have vague, nondescript symptoms. Serum antibody titers and liver function tests can be insufficiently elevated to be strongly supportive of either disease, and multiple serum antibody titers can be elevated, creating a nondiagnostic antibody panel. The distinction between the diseases is important. Corticosteroids, which are the mainstay of AIH therapy, usually are contraindicated in PBC. When the clinical findings and laboratory tests are inconclusive, the diagnosis can rest primarily on the morphologic features of the liver biopsy specimen. Unfortunately, liver biopsy specimens from patients with early-stage, mildly active PBC or AIH also can be nondiagnostic because they lack the characteristic morphologic features of either disease. Normal biliary epithelium is strongly cytokeratin 7 reactive. 4-6 Mature, uninjured hepatocytes are cytokeratin 7 nonreactive. 4,7 One author recently suggested that cytokeratin 7 immunohistochemical analysis could be helpful in the distinction of PBC and chronic hepatitis. 1,8 Many of the liver biopsy specimens in this study had late-stage changes with marked bridging fibrosis or cirrhosis and characteristic morphologic features. 8 The extent to which cytokeratin 7 immunohistochemical analysis could be diagnostically helpful in liver biopsy specimens from patients with early stage, mildly active PBC or AIH has not been explored fully. Three studies during the 1990s found an increased number of portal tract eosinophils in liver biopsy specimens from patients with PBC compared with patients with chronic hepatitis The majority of studied biopsies had late-stage changes, with marked bridging fibrosis or cirrhosis, and they 846 Am J Clin Pathol 2001;116: American Society of Clinical Pathologists
2 Anatomic Pathology / ORIGINAL ARTICLE also had characteristic morphologic features. The usefulness of portal tract eosinophils in liver biopsy specimens from earlystage, mildly active PBC and AIH also has not been studied. The goal of the present study was to evaluate whether portal tract eosinophils and cytokeratin 7 immunohistochemical analysis could be helpful in the morphologic distinction between mildly active, early-stage PBC and AIH, especially in biopsy specimens that are devoid of characteristic morphologic features. Materials and Methods The goal was to retrospectively obtain a group of nondiagnostic liver biopsy specimens from patients with earlystage, mildly active PBC or AIH who later had definite, unequivocal diagnoses of AIH or PBC. The studied liver biopsy specimens were selected from a large group of patients with PBC or AIH treated by one of us (S.C.G.) during the period January, 1, 1993, through July 1, At the time of the retrospective review, all patients with AIH in the group had definite AIH according to the International Autoimmune Hepatitis Scoring System (serum alanine transaminase level at least 5 times the upper limit of normal, serum IgG level at least 2 times the upper limit of normal, positive anti smooth muscle antibodies, and a liver biopsy specimen with moderate or severe periportal or periseptal lymphoplasmacytic piecemeal necrosis), and all patients with PBC had definite PBC (positive serum antimitochondrial antibodies, serum alkaline phosphatase level >2 times the upper limit of normal, serum glutamyltranspeptidase level at least 5 times the upper limit of normal, and a liver biopsy specimen with florid duct lesion). 12,13 We were not interested in characterizing these features in liver biopsy specimens with the characteristic morphologic features of PBC or AIH. Liver biopsy slides and pathology reports from the PBC and AIH patient pool were initially reviewed, and the biopsy specimens were excluded if they had extensive bridging fibrosis, cirrhosis, or characteristic morphologic features of PBC (moderate bile duct injury, bile duct centered lymphoplasmacytic inflammation, peri bile duct lymphoid aggregates, onion skin type peri bile duct fibrosis, portal or parenchymal granulomas, and isolated foreign body giant cells) or AIH (a low-magnification impression of parenchymal-centered inflammation; diffuse, moderate interface hepatitis; and moderate parenchymal inflammation, extensive hepatocyte necrosis, numerous foci of spotty inflammation with acidophilic bodies). 3,12 The clinical records of patients also were reviewed, and biopsy specimens were excluded if the patient was receiving corticosteroids or ursodeoxycholic acid at the time of biopsy, had additional liver diseases including B or C viral hepatitis (at the time of liver biopsy or subsequently diagnosed), had a subsequent diagnosis other than definite PBC or AIH, or was lost to follow-up before a definitive diagnosis could be established. Included biopsy specimens were from patients who were diagnosed with definite PBC or AIH at the time of the liver biopsy or after the biopsy. 12,14 None of the patients in the study had an overlap syndrome with moderate to markedly active features of both diseases. 13,15-18 The final study group included nondiagnostic liver biopsy specimens from 38 patients with definite PBC or AIH. Twenty biopsy specimens were from patients with PBC, and 18 were from patients with AIH. The mean age at biopsy for patients with AIH was 42 years and for patients with PBC, 47 years. All specimens from patients with PBC were predominantly stage 1 or Four (20%) had rare portal-portal fibrous bridges. None had extensive bridging fibrosis or cirrhosis. Thirteen patients with PBC had incorrect, nonspecific, or possible PBC diagnoses at the time of the liver biopsy; all biopsies were performed while under the care of nonauthor physicians. These patients came under the care of one of us (S.C.G.), and their disease was reclassified as probable or definite PBC 2.5 to 39 months after the liver biopsy. The other 7 patients with PBC had probable or definite PBC diagnoses made by one us (S.C.G.) at the time of liver biopsy. The majority of portal tracts in biopsy specimens from patients with AIH had portal fibrosis that was predominantly mild, and less commonly moderate. Ten biopsy specimens (56%) had rare, thin portal-portal fibrous septa. None had extensive bridging fibrosis or cirrhosis. Fourteen of 18 patients with AIH had incorrect or nonspecific hepatitis diagnoses at the time of the liver biopsy, and 3 had probable AIH. Ten patients underwent a second liver biopsy that showed characteristic AIH. A definitive AIH diagnosis was made by one of us (S.C.G.) 1 to 22 months after the initial liver biopsy. Specimen Processing and Staining All liver biopsy specimens were processed in a similar manner. Blank sections were serially cut after formalin fixation and sequentially stained with H&E, Masson trichrome, reticulin, periodic acid Schiff without diastase, periodic acid Schiff with diastase, Prussian blue, orcein, and H&E again. Sixteen biopsy specimens from each disease group with the greatest amounts of residual tissue in the blocks were used for cytokeratin 7 immunohistochemical staining. A 3- µm-thick section from each case was placed on a charged slide. Sections were deparaffinized using sequential immersions in 2 xylene baths, 3 baths of decreasing alcohol concentrations, and 2 water baths, followed by a 1-minute American Society of Clinical Pathologists Am J Clin Pathol 2001;116:
3 Goldstein et al / DISTINGUISHING PRIMARY BILIARY CIRRHOSIS FROM AUTOIMMUNE HEPATITIS wash in water. Slides were immersed in EDTA buffer (ph 7.0) and put into a commercial vegetable steamer at 95 C for 30 minutes. The slides were allowed to cool on the counter, remaining immersed in the heated EDTA buffer filled containers for 5 minutes, followed by a 2-minute rinse with water while remaining in the containers. The slides were transferred into tris(hydroxymethyl)aminomethane filled containers (ph 7.0) and allowed to undergo an additional 10 minutes of cooling on the countertop. They then were transferred to a commercial immunohistochemical autostainer (DAKO, Carpinteria, CA) and first were washed with buffer, followed by a hydrogen peroxide incubation. The latter was rinsed off, and the primary antibody was applied. Cytokeratin 7 (clone OV-TL-12/30; 1:800 dilution; DAKO) antibody was incubated over the sections for 20 minutes at room temperature. After the primary antibody was washed off, the components of the Envision-plus (DAKO) detection system were applied, including an antimouse polymer, 2 distilledwater washes, and a final diaminobenzidine incubation for 4 minutes. Sections were counterstained with hematoxylin, and cover glasses were applied. A positive control slide containing known cytokeratin-reactive tissues was stained with each batch of simultaneously stained slides. The chromogen system used was a 2-step technique that uses a horseradish peroxidase polymer conjugated with secondary antibodies. The labeled polymer does not contain avidin or biotin, and, therefore, nonspecific staining of hepatocytes from endogenous biotin is avoided. Evaluated Features The following features were evaluated in each biopsy specimen: Activity scores. Most of the liver biopsy specimens had a range of activity; therefore, a highest activity score was given based on the activity within the most active lobule in addition to the histologic activity index score. 20 Number of portal tract eosinophils. The number was quantified on a scale of 0 to 2+: 0, no eosinophils; 1+, eosinophils in less than one third of the portal tracts; 2+, eosinophils in more than one third of the portal tracts. Number of portal tracts available for evaluation. Mean number of central bile ducts per portal tract. Degree of central bile duct injury. The degree was scored as none, minimal, or mild. Minimal bile duct injury was a few intraepithelial lymphocytes unassociated with biliary epithelium injury; mild bile duct injury was slight lymphocyte infiltration of the duct with biliary epithelium cytoplasmic eosinophilia and nuclear irregularities. Number of cytokeratin 7 reactive hepatocytes. This feature was scored on a scale of 0 to 3+: 0, no cytokeratin 7 reactive hepatocytes; 1+, single or clusters of cytokeratin 7 reactive periportal hepatocytes located around fewer than 10% of the portal tracts; 2+, single or clusters of cytokeratin 7 reactive periportal hepatocytes around 10% to 50% of the portal tracts; 3+, reactivity around more than 50% of the portal tracts. The biopsy specimens were examined in a blinded fashion without knowledge of whether the patient had PBC or AIH, and a numeric score for each feature was recorded. Subsequently, the biopsy specimens from all patients with PBC followed by patients with AIH were grouped together and reviewed, and descriptions and qualitative characteristics of each feature were recorded. Results Inflammation The morphologic features of the PBC and AIH liver biopsy specimens were similar because of the restrictive study inclusion criteria. All specimens had portal tract and parenchymal (lobular) mixed lymphoplasmacytic inflammation that was not plasma cell predominant. The distribution of the inflammation was equal between portal tracts and lobules when mild and portal predominant when moderate. Most biopsy specimens had mild or mild to moderate portal inflammation, and a minority had moderate portal inflammation. The majority of portal tracts had no or mild piecemeal necrosis (interface hepatitis), and a minority had mild to moderate or moderate piecemeal necrosis. Parenchymal inflammation and injury was predominantly mild and focally moderate. The mean and range for the histologic activity index scores for the liver biopsy specimens from patients with PBC or AIH were 5.8 (range, 3-7) and 5.7 (range, 2-8), respectively Table 1. The mean of the greatest regional activity of the PBC biopsy specimens was 7.4 (range, 6-8); for AIH biopsy specimens, it was 8.7 (range, 7-9). Table 1 Morphologic Features in Liver Biopsy Specimens From Patients With Primary Biliary Cirrhosis (PBC) or Autoimmune Hepatitis (AIH) * Feature PBC (n = 20) AIH (n = 18) Portal eosinophil score (mean) Portal eosinophil score of 0 or (45) 12.0 (67) Periportal cytokeratin 7 reactive hepatocyte score (mean) Periportal cytokeratin 7 reactive hepatocyte score of 0 or (35) 18.0 (100) Minimal or mild bile duct damage 16.0 (80) 13.0 (72) Bile ducts/portal tract Histologic activity index score * Data are given as number (percentage) unless otherwise indicated. 848 Am J Clin Pathol 2001;116: American Society of Clinical Pathologists
4 Anatomic Pathology / ORIGINAL ARTICLE Image 1 Primary biliary cirrhosis. Portal tract with lymphoplasmacytic inflammation including admixed eosinophils. Inset, several eosinophils located near the bile duct (H&E, 56; inset, 112). Image 2 Autoimmune hepatitis. Portal tract with lymphoplasmacytic inflammation devoid of eosinophils (H&E, 64). Portal tract eosinophils were appreciably greater in liver biopsy specimens from patients with PBC than from patients with AIH Image 1 and Image 2. The majority of portal tracts in the biopsy specimens of patients with PBC with mild to moderate or moderate inflammation had several eosinophils centered around the bile duct. Portal tracts in PBC biopsy specimens with no or mild inflammation usually had no eosinophils. In contrast with the PBC liver biopsy specimens, moderately inflamed portal tracts from AIH specimens usually had no eosinophils or a rare eosinophil. The mean portal eosinophil scores in biopsy specimens from patients with PBC were 1.20 (range, 0-2) and from specimens from patients with AIH, 0.42 (range, 0-2). Despite the difference in mean scores, the percentages of biopsies with portal eosinophil scores of 0 or 1 were similar between the groups, constituting 45% (9/20) of the PBC biopsy specimens and 67% (12/18) of the AIH biopsy specimens. Portal Tracts, Bile Duct Number and Injury, and Bile Ductular Proliferation The mean number of portal tracts in PBC and AIH biopsy specimens was 12.6 (range, 7-24) and 10.2 (range, 6-19), respectively. The mean number of central bile ducts per portal tract in PBC and AIH biopsy specimens quantified on H&E-stained slides was 0.8 and 0.6, respectively. These values increased to 1.1 and 1.3, respectively, when the cytokeratin 7 stained slides were used to quantify the number of central bile ducts. Many central bile ducts that were obscured by portal inflammation on the H&E-stained slides became evident on the cytokeratin 7 stained slides. Approximately two thirds of the central bile ducts from both patient groups were round or oval, with an obvious central lumen. Some were partially flattened, producing a lumen of decreased diameter, and rare ducts were slit-shaped and devoid of a central lumen. Minimal and mild bile duct injuries were common in portal tracts with moderate inflammation in biopsy specimens from patients with PBC or AIH. The liver biopsy specimens from 16 patients with PBC (80%) and 13 patients with AIH (72%) had minimal bile duct damage. Ten biopsy specimens from patients with PBC (50%) and 4 from patients with AIH (22%) had mild bile duct damage. There was a bile ductular proliferation around portal tracts that were widened by fibrosis in PBC and AIH biopsy specimens. The proliferation tended to involve one third to one half of the portal tract circumference in PBC specimens, whereas it remained less than one third of the circumference in AIH biopsy specimens. Cytokeratin 7 Reactive Parenchymal Cells Three different-shaped cells could be seen with the cytokeratin 7 stain in addition to portal bile ducts and ductule cells, parenchymal spindle or stellate cells, small oval cells, and hepatocyte-like cells Image 3. Parenchymal spindle and stellate cells that usually were strongly cytokeratin 7 reactive were most numerous in areas of spotty parenchymal inflammation and, to a lesser degree, piecemeal necrosis. Oval cells that were approximately half the size of hepatocytes and devoid of prominent nucleoli usually had weak to moderate cytokeratin staining. These cells were found most American Society of Clinical Pathologists Am J Clin Pathol 2001;116:
5 Goldstein et al / DISTINGUISHING PRIMARY BILIARY CIRRHOSIS FROM AUTOIMMUNE HEPATITIS (75%) of 16 PBC biopsy specimens had cytokeratin 7 reactive periportal hepatocytes. Cytokeratin 7 reactive periportal hepatocytes were present around fewer than 10% of the portal tracts in 2 (12%) of 16 AIH biopsy specimens. The mean cytokeratin 7 reactive periportal hepatocyte score was 2.13 (range, 0-3) in PBC biopsy specimens and 0.13 (range, 0-1) in AIH biopsy specimens. Despite the differences in the mean values, 7 (35%) of 20 PBC biopsy specimens and 18 (100%) of 18 AIH biopsy specimens had periportal cytokeratin 7 hepatocyte scores of 0 or 1. Discussion Image 3 Autoimmune hepatitis. Cytokeratin 7 immunostain showing reactive bile ductules, parenchymal spindle cells, and small periportal oval cells. Inset, high magnification of the parenchymal spindle cell (arrowhead) and oval cell (arrow). The oval cell is approximately one half the dimension of the adjacent hepatocytes (hematoxylin counterstain, 56; inset, 112). often in the periportal parenchyma adjacent to active piecemeal necrosis. The number of these 2 cell types seemed to be similar in PBC and AIH biopsy specimens and was not explored further. Only cytokeratin 7 reactivity in periportal hepatocytelike cells was quantified Image 4 and Image 5. Twelve The liver biopsy specimens from patients with earlystage, mildly active PBC or AIH can be morphologically similar. 3,14,21-26 Liver biopsy specimens from patients with PBC can have mild, AIH-like piecemeal and parenchymal lymphoplasmacytic inflammation; and the portal tracts can be devoid of granulomas, lack bile duct centered inflammation, have only mild bile duct injury, and contain a minimal bile ductular proliferation. 18,24,27,28 Liver biopsy specimens from patients with early-stage, mildly active AIH can have portal tract centered inflammation that is of mild activity with mild bile duct damage and a slight bile ductular proliferation. 12,21,23,25,26,29,30 Dense portal inflammation can obscure bile ducts in either disease. 1,8 Some authors have classified biopsy specimens with morphologic features that could not be classified as AIH or PBC as nondiagnostic. 17 Two studies from the 1990s reported that portal tracts from PBC biopsy specimens had increased eosinophils Image 4 Primary biliary cirrhosis. Several cytokeratin 7 reactive periportal hepatocytes of weak to moderate intensity (hematoxylin counterstain, 112). Image 5 Primary biliary cirrhosis. Cluster of hepatocytes with cytokeratin 7 reactivity of moderate intensity (hematoxylin counterstain, 112). 850 Am J Clin Pathol 2001;116: American Society of Clinical Pathologists
6 Anatomic Pathology / ORIGINAL ARTICLE compared with those of chronic hepatitis. 9,10 Little attention was given to these observations until a more recent study confirmed that PBC biopsy specimens had an overall greater number of portal eosinophils and a greater number of activated portal eosinophils than biopsy specimens from patients with chronic hepatitis. 11 This study also found that ursodeoxycholic acid suppressed the number of activated circulating and intrahepatic eosinophils. The authors concluded that eosinophils were an active component of the inflammatory process in PBC, and the clinical effects of ursodeoxycholic acid in patients with PBC was through alterations in eosinophil degranulation. 11 We also found that portal eosinophils were increased in early-stage, mildly active PBC biopsy specimens compared with AIH biopsy specimens, supporting the findings of previous studies. However, portal eosinophils seemed to be a useful diagnostic morphologic feature of PBC only when most of the portal tracts had eosinophils. Approximately 50% of PBC and AIH biopsy specimens had a limited number of eosinophils in a minority of portal tracts. Decreased portal bile ducts is a characteristic morphologic feature of PBC. 1,8 Cytokeratin 7 immunohistochemical analysis facilitated the identification of bile ducts in portal tracts with dense inflammation where the bile duct was obscured. Although the H&E-stained sections and the recut sections used for cytokeratin 7 stains were not always similar, the mean number of bile ducts per portal tract increased approximately 37% when quantified on the cytokeratin 7 immunohistochemical section compared with the number identified on the H&E-stained slide. These values are similar to those of a study by Rubio. 1 Rubio 8 recommended that cytokeratin 7 stain be used whenever the evaluation of bile ducts is an important component of the diagnosis. We second this recommendation. Rubio 8 also noted from the examination of cytokeratin 7 stained sections that lumens were present in central bile ducts in 27% of PBC biopsy specimens and in 90% of AIH biopsy specimens. Our results differed. An equal percentage of PBC and AIH biopsy specimens had central bile ducts with lumens. One plausible explanation for these differences is that we studied only biopsy specimens from early-stage, mildly active disease, whereas some of the biopsy specimens evaluated by Rubio were of higher stage and had greater activity. Cytokeratin 7 reactive periportal hepatocytes located around the majority of portal tracts were found only in PBC biopsy specimens and, therefore, could be used as a morphologic feature of this disease. However, similar to portal eosinophils, the usefulness of this feature is limited when focal because 35% of PBC biopsy specimens and all AIH biopsy specimens had no or rare cytokeratin 7 reactive periportal hepatocytes around fewer than 10% of the portal tracts. It is difficult to compare the cytokeratin 7 staining results of the present study with those of other studies. No other study used a chromogen system that was independent of avidin and biotin, which is necessary to consider the weak staining of hepatocytes as a reliable result. One study noted that cytokeratin 7 reactive hepatocyte-like cells were found in some areas with moderate to severe parenchymal inflammation in biopsy specimens from patients with chronic viral hepatitis. 31 A recent study that focused on overlap syndromes and autoimmune liver diseases between the spectral ends of PBC and AIH found that 30% of PBC biopsy specimens and 100% of AIH biopsy specimens had cytokeratin 19 reactive periportal hepatocytes. 18 Most of the biopsy specimens in that study had greater amounts of fibrosis and active inflammation. 18 Regardless, we are at a loss to explain the disparate results between that study and ours. The recent study by Rubio 8 raises the question of the specific cells being evaluated by the previous authors. Similar to the results of our study, Rubio noted that cytokeratin 7 reactive periportal hepatocytes were present in PBC biopsy specimens with many peripheral bile ducts. These same cells were nonreactive for cytokeratin 19. After our reading of the studies by these authors, we recut 12 PBC biopsy specimens with the most cytokeratin 7 reactive periportal hepatocytes and stained them with cytokeratin 19. Identical to the findings of Rubio, the cytokeratin 7 reactive periportal hepatocytes were nonreactive for cytokeratin 19. The mechanism underlying periportal hepatocyte cytokeratin 7 reactivity in PBC biopsy specimens is unknown. One possibility is that it represents an early response by stem cells. These cells increase in the parenchyma immediately adjacent to portal tracts or within bile ductules at the periphery of portal tracts in long-term extrahepatic biliary obstruction. Some authors have speculated that this may be a proliferation of cells that normally reside in or compose the small ducts that connect bile canaliculi to the canals of Hering. 5,32-39 They can acquire the cytologic appearance of hepatocytes, yet have a bile duct or coexpress a bile duct and hepatocyte immunophenotype. 31,34,39-41 The existence of cells that possess the ability to undergo dual biliary and hepatocyte differentiation has been used to explain why otherwise typical hepatocytes around the periphery of cirrhotic nodules can have a bile duct type keratin immunophenotype Disruption of intrahepatic biliary flow, rather than inflammation and piecemeal necrosis, may induce this reaction because cytokeratin 7 expression in hepatocytes was not seen to any substantial degree in AIH biopsy specimens. H&E staining underestimated the number of bile ducts compared with cytokeratin 7 staining. Portal tract eosinophils and cytokeratin 7 reactive periportal hepatocytes American Society of Clinical Pathologists Am J Clin Pathol 2001;116:
7 Goldstein et al / DISTINGUISHING PRIMARY BILIARY CIRRHOSIS FROM AUTOIMMUNE HEPATITIS are supportive of PBC when present in moderate to extensive degrees. None of the studied features was morphologically supportive of AIH. A liver biopsy specimen with no portal eosinophils and no periportal hepatocytes does not exclude PBC and is not diagnostic of AIH. Pathologists should consider including a cytokeratin 7 stain when evaluating liver biopsy specimens from patients who may have intrahepatic biliary disease. From the Departments of 1 Anatomic Pathology and 2 Gastroenterology-Hepatology, William Beaumont Hospital, Royal Oak, MI. Address reprint requests to Dr Goldstein: Dept of Anatomic Pathology, William Beaumont Hospital, 3601 W Thirteen Mile Rd, Royal Oak, MI References 1. Rubio CA. The detection of bile ducts in liver biopsies by cytokeratin 7. In Vivo. 1998;12: Kaplan MM. Primary biliary cirrhosis. N Engl J Med. 1996;335: Portman BC, MacSween RNM. Diseases of the intrahepatic bile ducts. In: MacSween RNM, Anthony PP, Scheur PH, et al, eds. Pathology of the Liver. Edinburgh, Scotland: Churchill Livingstone; 1994: Fischer HP, Altmannsberger M, Weber K, et al. Keratin polypeptides in malignant epithelial liver tumors: differential diagnostic and histogenetic aspects. Am J Pathol. 1987;127: Ruck P, Xiao JC, Kaiserling E. Small epithelial cells and the histogenesis of hepatoblastoma: electron microscopic, immunoelectron microscopic, and immunohistochemical findings. Am J Pathol. 1996;148: Van Eyken P, Sciot R, Desmet VJ. Immunocytochemistry of cytokeratins in primary human liver tumors. APMIS Suppl. 1991;23: Van Eyken P, Sciot R, van Damme B, et al. Keratin immunohistochemistry in normal human liver: cytokeratin pattern of hepatocytes, bile ducts and acinar gradient. Virchows Arch A Pathol Anat Histopathol. 1987;412: Rubio CA. Qualitative and quantitative differences between bile ducts in chronic hepatitis and in primary biliary cirrhosis. J Clin Pathol. 2000;53: Terasaki S, Nakanuma Y, Yamazaki M, et al. Eosinophilic infiltration of the liver in primary biliary cirrhosis: a morphological study. Hepatology. 1993;17: Nakamura A, Yamazaki K, Suzuki K, et al. Increased portal tract infiltration of mast cells and eosinophils in primary biliary cirrhosis. Am J Gastroenterol. 1997;92: Yamazaki K, Suzuki K, Nakamura A, et al. Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis. Hepatology. 1999;30: Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31: Czaja AJ. Frequency and nature of the variant syndromes of autoimmune liver disease. Hepatology. 1998;28: Czaja AJ, Carpenter HA. Validation of scoring system for diagnosis of autoimmune hepatitis. Dig Dis Sci. 1996;41: Chazouilleres O, Wendum D, Serfaty L, et al. Primary biliary cirrhosis autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology. 1998;28: Czaja AJ. The variant forms of autoimmune hepatitis. Ann Intern Med. 1996;125: Czaja AJ, Carpenter HA, Santrach PJ, et al. Autoimmune cholangitis within the spectrum of autoimmune liver disease. Hepatology. 2000;31: Terracciano LM, Patzina RA, Lehmann FS, et al. A spectrum of histopathologic findings in autoimmune liver disease. Am J Clin Pathol. 2000;114: Ludwig J, Dickson ER, McDonald GSA. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histopathol. 1978;379: Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22: Czaja AJ, Carpenter HA. Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology. 1993;105: Kenny RP, Czaja AJ, Ludwig J, et al. Frequency and significance of antimitochrondrial antibodies in severe chronic active hepatitis. Dig Dis Sci. 1986;31: Geubel AP, Baggenstoss AH, Summerskill WHJ. Responses to treatment can differentiate chronic active liver disease with cholangitic features from primary biliary cirrhosis syndrome. Gastroenterology. 1976;71: Cooksley WG, Powell LW, Kerr JF, et al. Cholestasis in active chronic hepatitis. Am J Dig Dis. 1972;17: Passwell J, Theodor E, Cohen BE. Chronic active hepatitis with unusual histologic features. J Pediatr. 1971;79: Christofferson P, Dietrichson O, Faber V, et al. The occurrence and significance of abnormal bile duct epithelium in chronic aggressive hepatitis. Acta Pathol Microbiol Scand. 1972;80: Hashimoto E, Lindor KD, Homburger HA, et al. Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. Mayo Clin Proc. 1993;68: Metcalf JV, Mitchison HC, Palmer JM, et al. Natural history of early primary biliary cirrhosis. Lancet. 1996;348: Burgart LJ, Batts KP, Ludwig J, et al. Recent-onset autoimmune hepatitis: biopsy findings and clinical correlations. Am J Surg Pathol. 1995;19: Vyberg M. The hepatitis-associated bile duct lesion. Liver. 1993;13: Libbrecht L, Desmet VJ, van Damme B, et al. Deep intralobular extension of human hepatic progenitor cells correlates with parenchymal inflammation in chronic viral hepatitis: can progenitor cells migrate? J Pathol. 2000;192: Shah KD, Gerber MA. Development of intrahepatic bile ducts in humans: immunohistochemical study using monoclonal cytokeratin antibodies. Arch Pathol Lab Med. 1989;113: Gerber MA, Thung SN. Liver stem cells and development. Lab Invest. 1993;68: Am J Clin Pathol 2001;116: American Society of Clinical Pathologists
8 Anatomic Pathology / ORIGINAL ARTICLE 34. Haque S, Haruna Y, Saito K, et al. Identification of bipotential progenitor cells in human liver regeneration. Lab Invest. 1996;75: Sell S. Is there a liver stem cell? Cancer Res. 1990;50: Thorgeirsson SS. Hepatic stem cells. Am J Pathol. 1993;142: Hsia CC, Evarts RP, Nakatsukasa H, et al. Occurrence of oval-type cells in hepatitis B virus associated human hepatocarcinogenesis. Hepatology. 1992;16: Desmet VJ, Van Eyken P, Sciot R. Cytokeratins for probing cell lineage relationships in developing liver. Hepatology. 1990;12: Ruck P, Xiao JC, Pietsch T, et al. Hepatic stem-like cells in hepatoblastoma: expression of cytokeratin 7, albumin and oval cell associated antigens detected by OV-1 and OV-6. Histopathology. 1997;31: Demetris AJ, Seaberg EC, Wennerberg AE, et al. Ductular reaction after submassive necrosis in humans: special emphasis on analysis of ductular hepatocytes. Am J Pathol. 1996;149: Halme L, Karkkainen P, Isoniemi H, et al. Carbohydrate 19-9 antigen as a marker of non-malignant hepatocytic ductular transformation in patients with acute liver failure: a comparison with alpha-fetoprotein and carcinoembryonic antigen. Scand J Gastroenterol. 1999;34: Van Eyken P, Sciot R, Desmet VJ. A cytokeratin immunohistochemical study of alcoholic liver disease: evidence that hepatocytes can express bile duct type cytokeratins. Histopathology. 1988;13: Van Eyken P, Sciot R, Callea F, et al. A cytokeratin-immunohistochemical study of focal nodular hyperplasia of the liver: further evidence that ductular metaplasia of hepatocytes contributes to ductular proliferation. Liver. 1989;9: Van Eyken P, Sciot R, Desmet VJ. A cytokeratin immunohistochemical study of cholestatic liver disease: evidence that hepatocytes can express bile duct type cytokeratins. Histopathology. 1989;15: American Society of Clinical Pathologists Am J Clin Pathol 2001;116:
Autoimmune Hepatitis: Histopathology
REVIEW Autoimmune Hepatitis: Histopathology Stephen A. Geller M.D.*, Autoimmune hepatitis (AIH), a chronic hepatic necroinflammatory disorder, occurs mostly in women. AIH is characterized by prominent
More informationSlide 7 demonstrates acute pericholangitisis with neutrophils around proliferating bile ducts.
Many of the histologic images and the tables are from MacSween s Pathology of the Liver (5 th Edition). Other images were used from an online source called PathPedia.com. A few images from other sources
More informationAutoimmune Liver Diseases
2nd Pannonia Congress of pathology Hepato-biliary pathology Autoimmune Liver Diseases Vera Ferlan Marolt Institute of pathology, Medical faculty, University of Ljubljana Slovenia Siofok, Hungary, May 2012
More informationHwajeong Lee, MD, Robert T. Stapp, DO, Adrian H. Ormsby, MD, and Veena V. Shah, MD
Anatomic Pathology / Overlap Syndrome The Usefulness of IgG and IgM Immunostaining of Periportal Inflammatory Cells (Plasma Cells and Lymphocytes) for the Distinction of Autoimmune Hepatitis and Primary
More informationBasic patterns of liver damage what information can a liver biopsy provide and what clinical information does the pathologist need?
Basic patterns of liver damage what information can a liver biopsy provide and what clinical information does the pathologist need? Rob Goldin r.goldin@imperial.ac.uk Fatty liver disease Is there fatty
More informationPBC/AIH variant/ overlap syndrome vs PBC with hepatitic features?
22 November 2018 BD-IAP UK-LPG Liver Update PBC/AIH variant/ overlap syndrome vs PBC with hepatitic features? in a UDCA non-responder Dina G. Tiniakos Institute of Cellular Medicine, Faculty of Medical
More informationMinocycline as a Cause of Drug-Induced Autoimmune Hepatitis Report of Four Cases and Comparison With Autoimmune Hepatitis
Anatomic Pathology / MINOCYCLINE-INDUCED AUTOIMMUNE HEPATITIS Minocycline as a Cause of Drug-Induced Autoimmune Hepatitis Report of Four Cases and Comparison With Autoimmune Hepatitis Neal S. Goldstein,
More informationPITFALLS IN THE DIAGNOSIS OF MEDICAL LIVER DISEASE WITH TWO CONCURRENT ETIOLOGIES I HAVE NOTHING TO DISCLOSE CURRENT ISSUES IN ANATOMIC PATHOLOGY 2017
CURRENT ISSUES IN ANATOMIC PATHOLOGY 2017 I HAVE NOTHING TO DISCLOSE Linda Ferrell PITFALLS IN THE DIAGNOSIS OF MEDICAL LIVER DISEASE WITH TWO CONCURRENT ETIOLOGIES Linda Ferrell, MD, UCSF THE PROBLEM
More informationBiliary tract diseases of the liver
Biliary tract diseases of the liver Digestive Diseases Course Bucharest 2016 Rob Goldin r.goldin@imperial.ac.uk How important are biliary tract diseases? Hepatology 2011 53(5):1608-17 Approximately 16%
More informationCASE 1 Plasma Cell Infiltrates: Significance in post liver transplantation and in chronic liver disease
CASE 1 Plasma Cell Infiltrates: Significance in post liver transplantation and in chronic liver disease Maria Isabel Fiel, M.D. The Mount Sinai Medical Center New York, New York Case A 57 yo man, 7 months
More informationHistometric and Serial Section Observations of the Intrahepatic Bile Ducts in Primary Biliary Cirrhosis
GASTROENTEROLOGY 761326-1332, 1979 Histometric and Serial Section Observations of the Intrahepatic Bile Ducts in Primary Biliary Cirrhosis YASUNI NAKANUMA and GOROKU OHTA Second Department of Pathology,
More informationA Case of Autoimmune Hepatitis with Antimitochondrial Antibody and No Detectable Antinuclear Antibody
FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFF St. Marianna Med. J. Case Report Vol. 32, pp. 33 38, 2004 FFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFF A Case
More informationBritish Liver Transplant Group Pathology meeting September Leeds cases
British Liver Transplant Group Pathology meeting September 2014 Leeds cases Leeds Case 1 Male 61 years Liver transplant for HCV cirrhosis with HCC in January 2014. Now raised ALT and bilirubin,? acute
More informationRegeneration of hepatocyte buds in cirrhosis from intrabiliary stem cells
Journal of Hepatology 39 (2003) 357 364 www.elsevier.com/locate/jhep Regeneration of hepatocyte buds in cirrhosis from intrabiliary stem cells Olga Falkowski 1,, Hee Jung An 2,, I. Andreea Ianus 3, Luis
More informationPathogenesis of Cholangiolocellular Carcinoma: Possibility of an Interlobular Duct Origin
REVIEW ARTICLE Pathogenesis of Cholangiolocellular Carcinoma: Possibility of an Interlobular Duct Origin Fukuo Kondo 1,2 and Toshio Fukusato 2 Abstract Cholangiolocellular carcinoma (CoCC) is categorized
More informationResident, PGY1 David Geffen School of Medicine at UCLA. Los Angeles Society of Pathology Resident and Fellow Symposium 2013
Resident, PGY1 David Geffen School of Medicine at UCLA Los Angeles Society of Pathology Resident and Fellow Symposium 2013 85 year old female with past medical history including paroxysmal atrial fibrillation,
More informationBasic patterns of liver damage what information can a liver biopsy provide and what clinical information does the pathologist need?
Basic patterns of liver damage what information can a liver biopsy provide and what clinical information does the pathologist need? Rob Goldin r.goldin@imperial.ac.uk @robdgol FATTY LIVER DISEASE Brunt
More informationChronic Biliary Disease. Dr Susan Davies & Dr Bill Griffiths
Chronic Biliary Disease Dr Susan Davies & Dr Bill Griffiths Chronic Biliary Disease Terminology is confusing with pathologists and hepatologists using the same language BUT with different meanings. Chronic
More informationCase n 1 ( B 92 / 4208 ) Case n 2 ( B 00 / 8249 ) Case n 3 ( B 98 / 8352 )
Slide Seminar Case n 1 ( B 92 / 4208 ) 16 month-old girl. HBV serology +. Clinic in favour of chronic hepatitis. 4 portal triads! classification limited Viral B chronic hepatitis Mild activity (Fig. 1
More informationHow to Approach a Medical Liver Biopsy. 9 th Bryan Warren School of Pathology Pancreatic and Liver Pathology. Sarajevo, 6 th -7 th November 2015
1 A Brief Introduction to the Liver Sessions 9 th Bryan Warren School of Pathology Pancreatic and Liver Pathology Sarajevo, 6 th -7 th November 2015 Stefan Hübscher, Institute of Immunology & Immunotherapy,
More informationFat, ballooning, plasma cells and a +ANA. Yikes! USCAP 2016 Evening Specialty Conference Cynthia Guy
Fat, ballooning, plasma cells and a +ANA. Yikes! USCAP 2016 Evening Specialty Conference Cynthia Guy Goals Share an interesting case Important because it highlights a common problem that we re likely to
More informationLIVER TRANSPLANTATION FOR OVERLAP SYNDROMES OF AUTOIMMUNE LIVER DISEASES
LIVER TRANSPLANTATION FOR OVERLAP SYNDROMES OF AUTOIMMUNE LIVER DISEASES No conflict of interest Objectives Introduction Methods Results Conclusions Objectives Introduction Methods Results Conclusions
More information21/07/2017. Update on Autoimmune Biliary Disease. Changing Role of Liver Biopsy in PBC and PSC. Primary Biliary Cirrhosis Cholangitis
Primary Biliary Cirrhosis Cholangitis Update on Autoimmune Biliary Disease Changing Change in Nomenclature for PBC : From Cirrhosis to Cholangitis (EASL Panel, Beuers et al J Hepatol Nov 2015, Gut Nov
More informationExtrahepatic Biliary Obstruction. Ductal Diseases: Stones Tumors. Acute Injury: Viral Hepatitis Toxin (APAP/Etoh) Reye s Shock.
Extrahepatic Biliary Obstruction Stones Tumors Ductal Diseases: Ductal Diseases: Primary Biliary Primary Biliary Cirrhosis Cirrhosis Sclerosing Cholangitis Sclerosing Cholangitis Acute Injury: Viral Hepatitis
More informationA Spectrum of Histopathologic Findings in Autoimmune Liver Disease
Anatomic Pathology / HISTOPATHOLOGIC FINDINGS IN AUTOIMMUNE LIVER DISEASE A Spectrum of Histopathologic Findings in Autoimmune Liver Disease Luigi M. Terracciano, MD, 1 Roselyn A. Patzina, MD, 1 Frank
More informationAberrant Expression of Keratin 7 in Hepatocytes as a Predictive Marker of Rapid Progression to Hepatic Failure in Asymptomatic Primary Biliary
2015 69 3 137144 Aberrant Expression of Keratin 7 in Hepatocytes as a Predictive Marker of Rapid Progression to Hepatic Failure in Asymptomatic Primary Biliary Cirrhosis a a,b* a a a a a,b a a a,b c d
More informationPrimary Liver Carcinoma Arising in People Younger Than 30 Years
Anatomic Pathology / PRIMARY LIVER CARCINOMA Primary Liver Carcinoma Arising in People Younger Than 30 Years Walter M. Klein, MD, 1 Ernesto P. Molmenti, MD, 2 Paul M. Colombani, MD, 2 Davinder S. Grover,
More informationViral Hepatitis (I) Luigi Terracciano Department of Pathology University Hospital Basel. Basel,
Viral Hepatitis (I) Luigi Terracciano Department of Pathology University Hospital Basel Basel, 19. 04. 2016 Definition Hepatitis means inflammation of the liver characterized by a variable combination
More informationHepatic vein lesions in alcoholic liver disease:
Hepatic vein lesions in alcoholic liver disease: retrospective biopsy and necropsy study AD BURT, RNM MacSWEEN University Department of Pathology Western Infirmary, Glasgow J Clin Pathol 1986;39:63-67
More informationDiagnostic utility of IgG and IgM immunohistochemistry in autoimmune liver disease
Online Submissions: http://www.wjgnet.com/1007-9327office wjg@wjgnet.com doi:10.3748/wjg.v16.i4.453 World J Gastroenterol 2010 January 28; 16(4): 453-457 ISSN 1007-9327 (print) 2010 Baishideng. All rights
More informationOval Cell Numbers in Human Chronic Liver Diseases Are Directly Related to Disease Severity
American Journal of Pathology, Vol. 154, No. 2, February 1999 Copyright American Society for Investigative Pathology Oval Cell Numbers in Human Chronic Liver Diseases Are Directly Related to Disease Severity
More informationUpdate on Autoimmune Liver Disease. Role of Liver Biopsy in Autoimmune Hepatitis, PBC and PSC
Update on Autoimmune Liver Disease Role of Liver Biopsy in Autoimmune Hepatitis, PBC and PSC Stefan Hübscher, School of Cancer Sciences, University of Birmingham Dept of Cellular Pathology, Queen Elizabeth
More informationORIGINAL ARTICLES LIVER, PANCREAS, AND BILIARY TRACT
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2009;7:98 103 ORIGINAL ARTICLES LIVER, PANCREAS, AND BILIARY TRACT Serologic Markers Do Not Predict Histologic Severity or Response to Treatment in Patients With
More informationPathological Classification of Hepatocellular Carcinoma
3 rd APASL Single Topic Conference: HCC in 3D Pathological Classification of Hepatocellular Carcinoma Glenda Lyn Y. Pua, M.D. HCC Primary liver cancer is the 2 nd most common cancer in Asia HCC is the
More informationDiagnosing Autoimmune Hepatitis in Children: Is the International Autoimmune Hepatitis Group Scoring System Useful?
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2004;2:935 940 Diagnosing Autoimmune Hepatitis in Children: Is the International Autoimmune Hepatitis Group Scoring System Useful? REGAN L. EBBESON* and RICHARD
More informationPapillary Lesions of the Breast A Practical Approach to Diagnosis. (Arch Pathol Lab Med. 2016;140: ; doi: /arpa.
Papillary Lesions of the Breast A Practical Approach to Diagnosis (Arch Pathol Lab Med. 2016;140:1052 1059; doi: 10.5858/arpa.2016-0219-RA) Papillary lesions of the breast Span the spectrum of benign,
More informationACCME/Disclosures. The Overlap Syndromes: Do They Exist? Key Points and Questions 4/6/2016. Hans Popper Hepatopathology Society
ACCME/Disclosures The USCAP requires that anyone in a position to influence or control the content of CME disclose any relevant financial relationship WITH COMMERCIAL INTERESTS which they or their spouse/partner
More informationAmong the benign intraepithelial melanocytic proliferations, Inflamed Conjunctival Nevi. Histopathological Criteria. Resident Short Reviews
Resident Short Reviews Inflamed conjunctival nevi (ICN) may suggest malignancy because of their rapid growth and atypical histology. The objective of this study was to characterize the diagnostic features
More informationPitfalls in the diagnosis of well-differentiated hepatocellular lesions
2013 Colorado Society of Pathology Pitfalls in the diagnosis of well-differentiated hepatocellular lesions Sanjay Kakar, MD University of California, San Francisco Outline Hepatocellular adenoma: new WHO
More informationInterface hepatitis in PBC: Prognostic marker and therapeutic target
Interface hepatitis in PBC: Prognostic marker and therapeutic target Raoul Poupon Service d Hépatologie, Hôpital Saint-Antoine, Paris Faculté de Médecine Pierre & Marie Curie, Paris Key features of
More informationRole of Liver Biopsy. Role of Liver Biopsy 9/3/2009. Liver Biopsies in Viral Hepatitis: Beyond Grading and Staging
Liver Biopsies in Viral Hepatitis: Beyond Grading and Staging for further reference: Liver biopsy assessment in chronic viral hepatitis: a personal, practical approach Neil Theise, MD. Depts of Pathology
More informationDetection and Characterization of Hepatocellular Carcinoma by Imaging
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:S136 S140 Detection and Characterization of Hepatocellular Carcinoma by Imaging OSAMU MATSUI Department of Imaging Diagnosis and Interventional Radiology,
More informationThere is extensive literature addressing both the histopathologic
Approach to the Liver Biopsy in the Patient With Chronic Low-Level Aminotransferase Elevations Pathologists sometimes encounter a liver biopsy from an asymptomatic patient with unexplained low-level parenchymal
More informationAutoimmune hepatitis
Autoimmune hepatitis: Autoimmune hepatitis a spectrum within a spectrum Alastair Burt Professor of Pathology and Dean of Clinical Medicine Newcastle University Spectrum of autoimmune liver disease Autoimmune
More informationLIVER DISEASES. Pathology Department, Zhejiang University School of Medicine,
LIVER DISEASES Pathology Department, Zhejiang University School of Medicine, 马丽琴,maliqin198@zju.edu.cn Viral Hepatitis Cirrhosis of liver Liver cancer Viral Hepatitis DEFINITION Primary hepatic infections
More informationLiver Pathology in the 0bese
Liver Pathology in the 0bese Rob Goldin Centre for Pathology, Imperial College r.goldin@imperial.ac.uk Ludwig et al. Non-alcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.
More informationNottingham Patterns of liver fibrosis and their clinical significance
Nottingham 2006 Patterns of liver fibrosis and their clinical significance Alastair D Burt Professor of Pathology and Dean of Clinical Medicine University of Newcastle upon Tyne Collapse of reticulin
More informationPBC and PSC: Back to Basics
Disclosure No financial interest or other relationship with the manufacturer(s) of the product(s) or provider(s) of the service(s) that will be discussed in this presentation. PBC and PSC: Back to Basics
More informationKey Points: Autoimmune Liver Disease: Update for Pathologists from the Hepatologist s Perspective. Jenny Heathcote, MD. University of Toronto
Autoimmune Liver Disease: Update for Pathologists from the Hepatologist s Perspective Jenny Heathcote, MD University of Toronto Key Points: AILD comprise autoimmune hepatitis, primary biliary cirrhosis
More informationValue of copper-associated protein in diagnostic assessment of liver biopsy
J Clin Pathol 1983;36: 18-23 Value of copper-associated protein in diagnostic assessment of liver biopsy PAOLO GUARASCIO, FRANCES YENTIS, UGUR CEVIKBAS, BERNARD PORTMANN, ROGER WILLIAMS From the Liver
More informationDiagnostic Paediatric Pathology
Annals of Diagnostic Paediatric Pathology 2006, 10(1 2):37 42 Copyright by Polish Paediatric Pathology Society Annals of Comparison of histological changes in liver biopsy specimens in patients with biliary
More informationBSG/ACP annual course Royal College of Pathologists Infections and Inflammations of the Hepato-Biliary System Hepatitis B and D
BSG/ACP annual course Royal College of Pathologists Infections and Inflammations of the Hepato-Biliary System Hepatitis B and D Amar Paul Dhillon Royal Free & University College Medical School Thurs 10
More informationAutoimmune Hepatitis: Clinical Overview and Pathological Findings
6 Jan 2018 Vol 11 No.1 North American Journal of Medicine and Science Review Autoimmune Hepatitis: Clinical Overview and Pathological Findings Simpal Gill, MD* Pathology Laboratory services, Houston Medical
More informationHangzhou, 15 March Ulrich Beuers Department of Gastroenterology and Hepatology Academic Medical Center University of Amsterdam
Clinical Aspects of Primary Biliary Cirrhosis Hangzhou, 15 March 2008 Ulrich Beuers Department of Gastroenterology and Hepatology Academic Medical Center University of Amsterdam Epidemiology of Primary
More informationLiver histopathology of the hepatitis A virus infection: a comparison with hepatitis type B and
J Clin Pathol 1983;36:65-654 Liver histopathology of the hepatitis A virus infection: a comparison with hepatitis type B and non-a, non-b* PETER KRYGER, PER CHRISTOFFERSEN From the Enterovirus and Rubella
More informationSerum Hepatitis C Virus RNA Levels and Histologic Findings in Liver Allografts With Early Recurrent Hepatitis C
Serum Hepatitis C Virus RNA Levels and Histologic Findings in Liver Allografts With Early Recurrent Hepatitis C Young Nyun Park, MD; Peter Boros, MD, PhD; David Y. Zhang, MD, PhD; Patricia Sheiner, MD;
More informationAcute and Chronic Hepatitis John Hart, M.D. University of Chicago Medical Center
Acute and Chronic Hepatitis John Hart, M.D. University of Chicago Medical Center Acute Hepatitis Clinical Features Classically acute hepatitis is defined clinically as a significant (at least 2X elevation
More informationLIVER PHYSIOLOGY AND DISEASE
GASTROENTEROLOGY C opy ri~ht 1972 by The Williams & Wilkins Co. Vol. 62. No.3 Printed in U.S.A. LIVER PHYSIOLOGY AND DISEASE SPLENOMEGALY IN UNCOMPLICATED BILIARY TRACT AND PANCREATIC DISEASE PETER B.
More informationAASLD: Boston Rob Goldin
AASLD: Boston 2014 Rob Goldin r.goldin@imperial.ac.uk Autoimmune hepatitis 31 Does genuine acute autoimmune hepatitis have a better prognosis? 32 Patients with Autoimmune Hepatitis and Advanced Disease
More informationPathology of Acute Hepatitis A in Humans
Pathology of Acute Hepatitis A in Humans Comparison with Acute Hepatitis B TADAO OKUNO,.D., ATSUSHI SANO,.D., TAKESHI DEGUCHI,.D., YOSHINORI KATSUA,.D., TAKESHI OGASAWARA,.D., TAKESHI OKANOUE,.D., AND
More informationInterpretation of Biopsy Findings in the Transplant Liver
Interpretation of Biopsy Findings in the Transplant Liver Kirk D. Jones, MD and Linda D. Ferrell, MD W i several thousand liver transplants being performed each year and many patients being managed in
More informationThe clinical and histological features of chronic liver
ORIGINAL ARTICLES Impaired Regeneration of Biliary Cells in Human Chronic Liver Allograft Rejection. Special Emphasis on the Role of the Finest Branches of the Biliary Tree Marius C. van den Heuvel, 1
More informationFibrosis and other histological features in chronic hepatitis C virus infection: a statistical model
J Clin Pathol 1996;49:465-469 Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's NHS Trust, Cambridge CB2 2QQ V S Wong G J M Alexander Departnent of Histopathology
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Ocaliva (obeticholic acid) Page 1 of 6 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Ocaliva (obeticholic acid) Prime Therapeutics will review Prior Authorization
More informationPresentation and mortality of primary biliary cirrhosis in older patients
Age and Ageing 2000; 29: 305 309 Presentation and mortality of primary biliary cirrhosis in older patients JULIA L. NEWTON 1,DAVID E. JONES 2,JANE V. METCALF 2,JAY B. PARK 2,ALISTAIR D. BURT 2, MARGARET
More informationCASE 01 LA Path Slide Seminar 13 March, 08. Deepti Dhall, MD Department of Pathology and Laboratory Medicine Cedars-Sinai Medical Center
CASE 01 LA Path Slide Seminar 13 March, 08 Deepti Dhall, MD Department of Pathology and Laboratory Medicine Cedars-Sinai Medical Center Clinical History 60 year old male presented with obstructive jaundice
More informationPrimary Sclerosing Cholangitis and Cholestatic liver diseases. Ahsan M Bhatti MD, FACP Bhatti Gastroenterology Consultants
Primary Sclerosing Cholangitis and Cholestatic liver diseases Ahsan M Bhatti MD, FACP Bhatti Gastroenterology Consultants I have nothing to disclose Educational Objectives What is PSC? Understand the cholestatic
More informationOverview of PSC Making the Diagnosis
Overview of PSC Making the Diagnosis Tamar Taddei, MD Assistant Professor of Medicine Yale University School of Medicine Overview Definition Epidemiology Diagnosis Modes of presentation Associated diseases
More informationDhanpat Jain Yale University School of Medicine, New Haven, CT
Dhanpat Jain Yale University School of Medicine, New Haven, CT Case history 15 years old female presented with fatigue. Found to have features suggestive of cirrhosis with esophageal varices, splenomegaly
More informationDigestive and Liver Disease
Digestive and Liver Disease 42 (2010) 585 592 Contents lists available at ScienceDirect Digestive and Liver Disease journal homepage: www.elsevier.com/locate/dld Liver, Pancreas and Biliary Tract Intrahepatic
More informationCoordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma
Anatomic Pathology / CYTOKERATINS 7 AND 20 IN PROSTATE AND BLADDER CARCINOMAS Coordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma Nader H. Bassily,
More informationEvaluation of the revised versus the simplified scoring system in patients with autoimmune hepatitis
EXPERIMENTAL AND THERAPEUTIC MEDICINE 7: 131-136, 2014 Evaluation of the revised versus the simplified scoring system in patients with autoimmune hepatitis YI LI, MILIN PENG and GUOZHONG GONG Institute
More information2014 CURRENT ISSUES IN PATHOLOGY
2014 CURRENT ISSUES IN PATHOLOGY SPECIAL STAINS IN LIVER BIOPSY PATHOLOGY Sanjay Kakar, MD University of California, San Francisco Trichrome stain : (1) Assess degree of fibrosis. H&E stain is not reliable
More informationIntrahepatic Sarcomatoid Cholangiocarcinoma with Portal Vein Thrombosis: A Case Report 1
Intrahepatic Sarcomatoid Cholangiocarcinoma with Portal Vein Thrombosis: A Case Report 1 Jae-Hoon Lim, M.D., Jin Woong Kim, M.D., Suk Hee Heo, M.D., Yong Yeon Jeong, M.D., Heoung Keun Kang, M.D. A 53-year-old
More informationWT1, Estrogen Receptor, and Progesterone Receptor as Markers for Breast or Ovarian Primary Sites in Metastatic Adenocarcinoma to Body Fluids
Anatomic Pathology / WT1, ESTROGEN RECEPTOR, AND PROGESTERONE RECEPTOR IN CYTOLOGY OF BODY FLUIDS WT1, Estrogen Receptor, and Progesterone Receptor as Markers for Breast or Ovarian Primary Sites in Metastatic
More informationLIVER SPECIALTY CONFERENCE USCAP Maha Guindi, M.D. Clinical Professor of Pathology Cedars-Sinai Medical Center Los Angeles, CA
LIVER SPECIALTY CONFERENCE USCAP 2016 Maha Guindi, M.D. Clinical Professor of Pathology Cedars-Sinai Medical Center Los Angeles, CA Nothing to disclose Case History 47-year-old male, long standing ileal
More informationTwo Cases of Primary Sclerosing Cholangitis Overlapping with Autoimmune Hepatitis in Adults
CASE REPORT Two Cases of Primary Sclerosing Cholangitis Overlapping with Autoimmune Hepatitis in Adults Go Igarashi 1, Tetsu Endo 1, Kenichiro Mikami 1, Naoya Sawada 1,RyuSatake 1, Rie Ohta 1, Juichi Sakamoto
More informationInvited Re vie W. Analytical histopathological diagnosis of small hepatocellular nodules in chronic liver diseases
Histol Histopathol (1 998) 13: 1077-1 087 http://www.ehu.es/histoi-histopathol Histology and Histopathology Invited Re vie W Analytical histopathological diagnosis of small hepatocellular nodules in chronic
More informationHOW TO DEAL WITH THOSE ABNORMAL LIVER ENZYMES David C. Twedt DVM, DACVIM Colorado State University Fort Collins, CO
HOW TO DEAL WITH THOSE ABNORMAL LIVER ENZYMES David C. Twedt DVM, DACVIM Colorado State University Fort Collins, CO The identification of abnormal liver enzymes usually indicates liver damage but rarely
More informationNon-Cirrhotic Portal Hypertension and Incomplete Septal Cirrhosis. Stefan Hübscher, University of Birmingham, Birmingham B15 2TT, U.K.
Non-Cirrhotic Portal Hypertension and Incomplete Septal Cirrhosis Stefan Hübscher, University of Birmingham, Birmingham B15 2TT, U.K. Non-Cirrhotic Portal Hypertension Problems with Liver Biopsy Diagnosis
More informationUncommon pattern in soft tissues epithelioid sarcoma
Romanian Journal of Morphology and Embryology 2005, 46(3):229 233 Uncommon pattern in soft tissues epithelioid sarcoma CARMEN ARDELEANU 1, 2), MARIA COMĂNESCU 3), VIOLETA COMĂNESCU 4), F. ANDREI 1) 1)
More informationLiver Pathology: Cirrhosis, Hepatitis, and Primary Liver Tumors. Update and Diagnostic Problems
SHORT COURSE Liver Pathology: Cirrhosis, Hepatitis, and Primary Liver Tumors. Update and Diagnostic Problems Linda Ferrell, M.D. Department of Anatomic Pathology, University of California San Francisco,
More informationGross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of
Tiền liệt tuyến Tiền liệt tuyến Gross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of solid and microcystic areas.
More informationPrognosis of untreated Primary Sclerosing Cholangitis (PSC) Erik Christensen Copenhagen, Denmark
Prognosis of untreated Primary Sclerosing Cholangitis (PSC) Erik Christensen Copenhagen, Denmark Study of Prognosis of PSC Difficulties: Disease is rare The duration of the course of disease may be very
More informationAutoimmune Pancreatitis: A Great Imitator
Massachusetts General Hospital Harvard Medical School Autoimmune Pancreatitis: A Great Imitator Dushyant V Sahani MD dsahani@partners.org Autoimmune Pancreatitis: Learning Objectives Clinical manifestations
More informationDILI PATHOLOGY. PHILIP KAYE November 2017 BSG Pathology Winter Meeting
DILI PATHOLOGY PHILIP KAYE November 2017 BSG Pathology Winter Meeting General Mechanisms Role of Liver Biopsy Outline Kleiner Categories Pathology! Differentials Severity Finally Drugs/Toxins may cause
More informationIn 1993, the International Autoimmune Hepatitis Group
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2012;10:417 421 Validation and Modification of Simplified Diagnostic Criteria for Autoimmune Hepatitis in Children ELIZABETH MILETI,* PHILIP ROSENTHAL,*, and MARION
More informationA 53 year-old woman with a lung mass, right hilar mass and mediastinal adenopathy.
November 2015 Case of the Month A 53 year-old woman with a lung mass, right hilar mass and mediastinal adenopathy. Contributed by: Rasha Salama, M.D., IU Department of Pathology and Laboratory Medicine
More informationOriginal Article. Human hepatic met-enkephalin and delta opioid receptor-1 immunoreactivities in viral and autoimmune hepatitis.
medigraphic Artemisa en línea VD Boyella Annals et al. of Met-enkephalin Hepatology 8; and 7(3): delta July-September: opioid receptor in 221-225 liver disease 221 Original Article Annals of Hepatology
More informationNoncirrhotic Portal Hypertension and Pathology of the Sinusoids. Ian R. Wanless Department of Pathology Dalhousie University Halifax, Canada
Noncirrhotic Portal Hypertension and Pathology of the Sinusoids Ian R. Wanless Department of Pathology Dalhousie University Halifax, Canada Non cirrhotic portal hypertension Extrahepatic portal vein obstruction
More informationExplain the laboratory diagnosis of Rabies?
Explain the laboratory diagnosis of Rabies? The standard test for rabies testing is dfa. This test has been thoroughly evaluated for more than 40 years, and is recognized as the most rapid and reliable
More informationS ince the discovery of hepatitis C, there have been several
402 ORIGINAL ARTICLE Steatosis and fibrosis in patients with chronic hepatitis C J Wyatt, H Baker, P Prasad, Y Y Gong, C Millson... See end of article for authors affiliations... Correspondence to: Dr
More informationSteatotic liver disease
Steatotic liver disease Fatty liver disease Prof. Dr. ANNE HOORENS Non-Neoplastic Liver Pathology December 8th 2018 Working Group of Digestive Pathology Belgian Society of Pathology OUTLINE NAFLD = Non-Alcoholic
More informationSingle and Multiplex Immunohistochemistry
Single and Multiplex Immunohistochemistry Steve Westra, BS Reagent Product Specialist Leica Biosystems IHC Theory Polyclonal vs Monoclonal Polyclonal reagents Detect a multitude of epitopes Batch to batch
More information1 NORMAL HISTOLOGY AND METAPLASIAS
1 NORMAL HISTOLOGY AND METAPLASIAS, MD Anatomy and Histology 1 Metaplasias 2 ANATOMY AND HISTOLOGY The female breast is composed of a branching duct system, which begins at the nipple with the major lactiferous
More informationInt J Clin Exp Pathol 2013;6(5): /ISSN: /IJCEP Tadashi Terada
Int J Clin Exp Pathol 2013;6(5):889-896 www.ijcep.com /ISSN:1936-2625/IJCEP1301031 Original Article Ductal plate in hepatoblasts in human fetal livers: I. ductal plate-like structures with cytokeratins
More informationDr/ Sherein Saeid AbdElgayed, ph.d
هللامسب Dr/ Sherein Saeid AbdElgayed, ph.d Professor of Veterinary Pathology, Cairo University, Giza, Egypt. Chairman of the Editorial Board of Arab Journal of Science & Research Publishing (AJSRP) http://www.ajsrp.com
More informationEvaluation of the diagnostic value of immunocytochemistry and in situ hybridization in the pediatric leprosy
Indian J Lepr 203, 85 : 93- Hind Kusht Nivaran Sangh, New Delhi http://www.ijl.org.in Original Article Evaluation of the diagnostic value of immunocytochemistry and in situ hybridization in the pediatric
More informationImmunofluorescent detection of a1-antitrypsin in
J. clin. Path., 1975, 28, 717-721 Immunofluorescent detection of a1-antitrypsin in paraffin embedded liver tissue M. B. RAY AND V. J. DESMET From the Laboratorium voor Histochemie en Cytochemie, Departement
More informationDo Histological Features Inform DILI mechanisms?
Do Histological Features Inform DILI mechanisms? Drug-Induced Liver Injury (DILI) Conference XVII June, 2017 David Kleiner, M.D., Ph.D. NCI/Laboratory of Pathology Disclosures No financial or other conflicts
More information